Insider Transactions in Q3 2025 at Atri Cure, Inc. (ATRC)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 12
2025
|
Justin J Noznesky Chief Mktg & Strategy Officer |
SELL
Open market or private sale
|
Direct |
3,000
-3.45%
|
$108,000
$36.3 P/Share
|
|
Aug 22
2025
|
Sven Wehrwein Director |
SELL
Open market or private sale
|
Direct |
5,000
-12.7%
|
$185,000
$37.0 P/Share
|
|
Aug 22
2025
|
Sven Wehrwein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.27%
|
$95,000
$19.95 P/Share
|
|
Aug 19
2025
|
Sven Wehrwein Director |
SELL
Open market or private sale
|
Direct |
5,000
-12.7%
|
$180,000
$36.0 P/Share
|
|
Aug 19
2025
|
Sven Wehrwein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.27%
|
$95,000
$19.95 P/Share
|
|
Aug 06
2025
|
Regina E Groves Director |
SELL
Open market or private sale
|
Direct |
2,452
-6.78%
|
$88,272
$36.82 P/Share
|
|
Aug 05
2025
|
Vinayak Doraiswamy Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,500
-3.36%
|
$90,000
$36.58 P/Share
|